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Tinnitus, the perception of an auditory phantom sound in the form of ringing, buzzing,
roaring, or hissing in the absence of an external sound source, is perceived by ∼15% of
the population and 2.5% experiences a severely bothersome tinnitus. The contribution
of genes on the development of tinnitus is still under debate. The current manuscript
reports a pilot Genome Wide Association Study (GWAS) into tinnitus, in a small cohort
of 167 independent tinnitus subjects, and 749 non-tinnitus controls, who were collected
as part of a cross-sectional study. After genotyping, imputation, and quality checking,
the association between the tinnitus phenotype and 4,000,000 single-nucleotide
polymorphisms (SNPs) was tested followed by gene set enrichment analysis. None of
the SNPs reached the threshold for genome-wide significance (p < 5.0e–8), with the
most significant SNPs, situated outside coding genes, reaching a p-value of 3.4e–7. By
using the Genetic Analysis of Complex Traits (GACT) software, the percentage of the
variance explained by all SNPs in the GWAS was estimated to be 3.2%, indicating that
additive genetic effects explain only a small fraction of the tinnitus phenotype. Despite the
lack of genome-wide significant SNPs, which is, at least in part, due to the limited sample
size of the current study, evidence was found for a genetic involvement in tinnitus. Gene
set enrichment analysis showed several metabolic pathways to be significantly enriched
with SNPs having a low p-value in the GWAS. These pathways are involved in oxidative
stress, endoplasmatic reticulum (ER) stress, and serotonin reception mediated signaling.
These results are a promising basis for further research into the genetic basis of tinnitus,
including GWAS with larger sample sizes and considering tinnitus subtypes for which a
greater genetic contribution is more likely.
Keywords: genome-wide association study, tinnitus, heritability, GWAS, phenotype, oxidative stress, serotonin,
gene set enrichment analysis
INTRODUCTION
Tinnitus is the perception of a sound which can be perceived as hissing, ringing, buzzing, or roaring
in the absence of an external sound source. It is therefore often referred to as an auditory phantom
sound (Eggermont and Roberts, 2004). The prevalence of tinnitus in the adult population is∼15%
(Seidman and Jacobson, 1996; Gilles et al., 2012, 2013), and in 2.5% of the population, the tinnitus
Gilles et al. GWAS on Tinnitus
causes significant burden (Axelsson and Ringdahl, 1989). The
evolvement of incapacitating tinnitus may lead to social isolation,
anxiety, depression, sleep disorders, and concentration issues
severely affecting ones quality of life (Henry et al., 2005).
The causes of tinnitus have been extensively investigated
over the years. Tinnitus appears as a symptom with increasing
prevalence with age. Tinnitus appears to emerge from a complex
interaction between aging, diseases, auditory malfunctions,
and environmental stressors. In 50% of the cases, tinnitus is
attributable to otologic malfunctions (hearing loss, noise trauma,
Ménière disease, vestibular schwannoma, temporomandibular
junction disorder, ototoxic medications, or substances etc.)
(Gilles et al., 2014). In others, the tinnitus is a result of neurologic,
metabolic, and/or psychogenic disorders (Crummer and Hassan,
2004). Environmental factors increasing the chances to develop
tinnitus are recreational and work-related noise exposure
(Sindhusake et al., 2003; Kim et al., 2015), smoking, sleep
deprivation (Park et al., 2014; Schecklmann et al., 2015), stress
(Nondahl et al., 2011), smaller households (Kim et al., 2015),
and obesity (Gallus et al., 2015; Martines et al., 2015) whereas
high household income and moderate alcohol consumption
are considered to be inversely related to tinnitus occurrence
(Nondahl et al., 2011; Gallus et al., 2015).
In contrast to the largely known environmental risk factors
for tinnitus, less is known about the genes involved. Many
genes have been put forward for possibly underlying tinnitus
susceptibility but no consensus has been reached so far. An
important complicating factor is the heterogeneity in tinnitus
causes and types (Sand et al., 2010; Pawelczyk et al., 2012;
Elgoyhen et al., 2014; Lopez-Escamez et al., 2016). In several
monogenic disorders associated with secondary chronic tinnitus,
such as neurofibromatosis type II, episodic ataxia type II,
osteogenesis imperfecta type I and Fabry disease, causative genes
have been identified. For an overview of monogenic diseases
associated with secondary tinnitus and its associated mutated
genes, we refer the reader to Sand et al. (2007). The role of
genetics in the more common types of primary, chronic tinnitus
in a healthy population, is under debate as data on primary
chronic tinnitus heritability is very limited and family and/or
twin studies are mostly lacking. The study of Kvestad et al. (2010)
was the first large population-based family study to provide an
estimation of the relative contribution of genetic effects on the
susceptibility to tinnitus. The data were collected by use of a
self-report questionnaire including questions concerning tinnitus
characteristics (duration, distress, frequency) and first-degree
family relationships. In total, a sample of 12,294 spouses, 27,607
parent-offspring, and 11,498 siblings was used for structural
equationmodeling. A heritability of 11%was obtained suggesting
that the involvement of genetic factors in tinnitus is rather low
(Kvestad et al., 2010).
It seems unlikely that families with hereditary tinnitus are
under-reported in the literature given the large number of
families reported with hereditary hearing loss. Therefore, the lack
of reported families showing a Mendelian pattern of inheritance,
probably indicates that primary chronic tinnitus is not a single-
gene disorder but rather a complex trait, controlled by complex
interactions between multiple genes and environmental risk
factors. In recent years, much effort has been devoted to the
genetic elucidation of the genes involved in complex traits.
This showed that most complex traits and diseases are highly
polygenic, involving the combined action of a multitude of
genetic variants, each of which having small effect sizes. Odds
ratios are typically smaller than 1.1, although variants with a
larger effect size (odds ratios above 1.25) have been reported
(Michailidou et al., 2015). For tinnitus, the previously estimated
heritability of 11% suggests that only a small fraction of the
variance is due to genetic variants. However, since the heritability
represents the variance accounted for by the combined effect of
several genes, it cannot be excluded that the number of involved
genes is limited, and that one or more major genes account for
most of the heritability. A recent study provides novel insights
into the genetic contribution to tinnitus. This longitudinal study
in a male twin cohort investigated the genetic contribution to
tinnitus revealing a ratio of 40/60% for, respectively, genetic and
environmental influences. These genetic influences for tinnitus
were independent of those for hearing loss (Bogo et al., 2016).
Genome-wide association studies (GWAS) are the method of
choice to identify the genes involved in complex diseases. In a
GWAS, genotypes from many single nucleotide polymorphisms
(SNPs) throughout the entire genome (often 1 million or more)
are determined and tested for association with the disease status.
A strong association between a particular SNP can indicate a
possible role of the variant (or the gene in which it resides) in the
pathophysiology of the disease. To date, more than 2000 different
disease-associated variants have been identified through GWAS
analysis, providing many new insights into the pathophysiology
of several diseases and traits (Welter et al., 2014).
The authors of the present manuscript previously carried
out a GWAS on age-related hearing impairment (ARHI) for
which a highly polygenic character of ARHI was shown, with
presumably no major genes involved (Fransen et al., 2015). In
the ARHI dataset, 18% of the participants reported to perceive
tinnitus. The aim of the current study was to gain an insight into
the genetic influence of SNPs on the tinnitus phenotype using
the genome-wide SNP data from the previously collected ARHI
dataset.
METHODS
Ethics Approval
The collection of the original ARHI dataset was approved by the
ethics committee of the University Hospital Antwerp on October
22, 2002 (file #A02-055).
Sample Collection
The local city councils in southern Antwerp (Belgium) made
population registries available by which a population-based
sample could be obtained. It was requested that at least three out
of the four grandparents originated from Belgium which made
the population ethnically homogenous. All responding subjects
underwent clinical examination, otoscopy, and completed a
detailed questionnaire on medical history and exposure to
environmental risk factors. A list of all questions and answers
used in this study is available on request.
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Strict exclusion criteria were applied to exclude persons
having or having had a condition that possibly leads to hearing
impairment. No phenotypic inclusion criteria were used for the
sample collection. Subjects with ear diseases, possible monogenic
forms of hearing impairment or other major pathologies with
a possible influence on hearing, were excluded. The main goal
was to study healthy subjects and therefore persons with multiple
hospitalizations were excluded. The extensive, complete list of
exclusion criteria was previously reported (Van Eyken et al., 2006)
and is provided as Supplementary Information (Supplement 1).
Pure tone audiometry was measured in all participating
subjects according to the current clinical standards (ISO 8253-
1, 2010) using a two-channel Interacoustics AC-40 audiometer in
a soundproof booth. Air conduction thresholds were measured at
125, 250, 500Hz, 1, 2, 4, and 8 kHz. Bone conduction thresholds
were measured within the range of 250Hz and 4 kHz.
The phenotype of tinnitus was scored in a very basic fashion
using the question “Nowadays, do you ever hear noises in your
head or ear(s) (tinnitus) which usually last longer than 5 min?”
No further phenotyping of tinnitus was performed as this was
a retrospective study to initially identify genes involved in age-
related hearing impairment (Fransen et al., 2015). Noise exposure
was addressed through the question “Have you ever worked for
more than a year in an environment where you had to shout to
an individual standing at less than a meter from you.”
Collection of the study subjects was cross-sectional with
no enrichment for any phenotype. However, the selection of
the genotyped samples was based upon audiometric criteria
as discussed in Fransen et al. (2015). In brief, the pure-tone
thresholds from 250, 500, 1000, 2000, 4000, and 8000Hz on age,
age2, and age3 were regressed, fitting separate models for males
and females. Subsequently, principal component analysis was
performed on the residuals. Principal component (PC) scores for
PC1, PC2, and PC3 were calculated. Since the aim was to obtain
a maximal statistical power to detect genes involved in hearing
loss, the phenotypically most extreme individuals for the three
PC scores were selected for genotyping.
Genotyping
DNA was extracted from blood samples using standard
procedures. GenomicDNA concentrations were determinedwith
PicoGreen (Invitrogen, Carlsbad, CA, USA). Additionally, the
quality of the genomic DNA was assessed for each sample by
gel electrophoresis. Five-hundred DNA samples were genotyped
with the Illumina CNV370 quad chip, 1060 DNA samples using
the Illumina HumanOmniExpress BeadChip (Illumina, Inc., San
Diego, CA, USA).
Imputation and Filtering
Pre-imputation filtering was carried out to exclude SNPs with a
minor allele frequency (MAF) below 1%, a p-value for Hardy-
Weinberg equilibrium below 1.0e–6, a call rate below 95% across
all samples and across all SNPs. Duplicate samples were identified
using pi-hat analysis (pi-hat> 0.99). For each of these duplicates,
the sample with the lowest genotyping call rate was removed.
Imputation was performed using the program impute2,
version 2.1.2 (Howie et al., 2009) with the 1000 Genomes Phase 1
Interim panel (June 2011) as reference panel. Imputation resulted
in a total of 11 626 570 SNPs. An additional post-imputation
filtering was carried out using the same exclusion criteria as
in the pre-imputation stage, and removing imputed SNPs with
an Impute2 info metric below 0.5. Gene boundaries used for
mapping SNPs onto genes are: 110 kb upstream to the most
extreme gene transcript start position, and 40 kb downstream
to the most extreme gene transcript end position, taking gene
orientation into account.
Association Analysis
Association between the tinnitus status (affected or not affected)
and the common variant genotypes (MAF > 0.01) was tested
using the logistic regression option in the software package
PLINK v1.07. An additive model was fitted taking the affection
status as a dependent variable. This analysis tests for the main
effect of a SNP on the tinnitus phenotype.
The effect of SNP genotype to noise sensitivity was tested
using logistic regression by fitting a model with SNP genotype,
noise exposure, and their interaction. Two significance tests were
carried out on this model: first the significance on the interaction
term (1df-test) was tested as well as the joint significance of the
SNP genotype and the interaction term (2df-test).
Heritability Estimates
The cumulative effect of all genotyped SNPs on the phenotypic
variance was estimated through variance component analysis
using the genomic-relatedness-based restricted maximum-
likelihood (GREML) method implemented in the Genetic
Analysis of Complex Traits (GACT) software (Yang et al.,
2011). All SNPs that passed the quality control were included.
The Genetic Relationship Matrix was estimated correcting for
incomplete Linkage Disequilibrium (LD) between genotyped
and causative variants. The percentage of variance explained by
the SNPs is obtained as the ratio of the genetic variance to the
total variance.
The presence of genome-wide gender-specific effects was
tested using a likelihood ratio test, comparing the models with
and without a variance component for gene-sex interaction, as
implemented in GACT.
Gene Set Enrichment Analysis
Gene set enrichment analysis was performed using the software
package MAGENTA (Meta-Analysis Gene-set Enrichment of
varianT Associations; Segre et al., 2010). This program first
expresses the significance of a whole gene as a gene score,
based upon the individual p-values of the SNPs within the gene,
adjusting for confounders (gene size, number of SNPs within
the gene, amount of LD, and number of recombination hotspots
within the gene). Subsequently, gene scores are combined at the
level of gene sets, whereby the p-values of a given gene set are
generated by counting the fraction of the genes within that gene
set that have a gene score above a predefined enrichment cut-
off. As recommended by the authors, the 75th percentile of all
observed gene scores was used as enrichment cut-offs to generate
the p-values for the individual pathways. Correction for multiple
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testing was performed using the False Discovery Rate (FDR)
method.
Analysis was performed using the p-values of the GWAS,
using the three tests (main effects, interaction test, and joint
test) as discussed earlier. SNPs were mapped to genes using
Genome build36 (hg18), using gene sets from the following
databases: Gene Ontology (April 2010), PANTHER (January
2010), Ingenuity (June 2008), KEGG (2010), Reactome and
BioCarta.
RESULTS
Sample Collection
All individuals in this study were recruited through population
registries in a residential suburb of Antwerp, Belgium. No
enrichment for any phenotype was carried out, but strict
exclusion criteria were applied to exclude individuals having
or having had a disease with a possible influence on hearing.
A detailed list with the exclusion criteria is provided as
Supplementary Data (Supplement 1). All individuals were of
Belgian ancestry. In total, 2161 individuals were randomly
collected in a cross-sectional way. Of these, 1560 were selected for
genotyping based upon audiometric data described in Fransen
et al. (2015). Of these genotyped individuals, tinnitus information
was available for 916 persons (456 females and 460 males), of
which 167 (18%) were reporting episodes of tinnitus lasting
longer than 5 min and the remaining 749 did not. The fraction
of individuals with tinnitus was significantly different between
males and females. Twenty-two percent of the males in the
dataset reported tinnitus, against only 15% of the females (p =
0.006, chi-square test; odds ratio = 1.61 with 95% confidence
interval 1.15–2.27). This difference may, at least in part, be due
to a difference in noise exposure: 94 of the 167 tinnitus patients
reported having worked in a noisy environment for more than a
year. Only 13 of them were female, vs. 81 males (p < 0.001, chi-
square test). Table 1 provides an overview of the characteristics
of the affected and non-affected individuals in this study.
Association Testing
All association tests were carried out on the 916 individuals with
a known tinnitus status, with the 167 tinnitus patients as cases
and the 749 non-tinnitus individuals as controls.
Three types of statistical tests were performed to test the
effect of the SNP genotypes on tinnitus. First, the main effect
of the SNPs on the phenotype was tested, via the association
between tinnitus, and the genotype without accounting for noise
exposure. This highlights the SNPs that lead to an increased
risk for tinnitus across both noise-exposed and non-exposed
individuals. Results of this analysis are shown in the table
“MainEffect” (Supplement 2). None of the SNPs reached the
threshold for genome-wide significance (p < 5.0e–8). The most
significant SNPs reach a p-value of 3.4e–7. Two genes contain
SNPs with a p-value below 1.0e–5 (VDAC1 and NKTR). The
significance of the SNPs is graphically shown in a Manhattan plot
in Figure 1, where the p-value is plotted vs. the chromosomal
location. The SNPs within a coding gene, with a p-value below
1.0e–5, are shown in green.
TABLE 1 | Social-demographic factors of the study population.
Affected by tinnitus Control N
Total population 167 749 916
Belgian ethnic origin 167 (100%) 749 (100%)
Age range 55–65 55–65
Mean age (st. deviation) 61.2 (3.1) 61.4 (3.1)
Number of males (%) 100 (60%) 360 (48%) 460
Noise exposure data available 164 (98%) 733 (98%) 897
Noise exposure (%) 23 (14%) 71 (10%) 897
Since it is known that noise exposure is a risk factor for
tinnitus, the interaction between the SNPs and noise exposure
was analyzed. This analysis would identify SNPs having a
different effect on the phenotype depending on noise exposure.
For instance, it could identify SNPs that render an individual
susceptible to tinnitus, following noise. These SNPs would not
be identified in the first analysis, as their effect on the phenotype
depends on noise exposure. P-values for this interaction were
calculated in two ways: the significance of the interaction term
and the joint test for genotype and interaction with noise In
general, p-values for the joint test are more significant than those
for the interaction test, but not as significant as the p-values for
the main effects. Genic SNPs in three genes (VDAC1, NKTR,
and COG3) reach a p-value below 1.0e–5 for the joint test, as
highlighted in the Manhattan plots (Figures 2, 3).
Tables with results are provided as Supplementary Materials
(Supplement 2). These tables have been sorted by p-value (most
significant value on top), and show the SNPs with a p-value
below 0.0001. The far right column (“ANNOT”) shows the gene
in which the SNP is located. If the SNP is further than 110 kb
upstream the most extreme gene transcript start site of a coding
gene, or more than 40 kb downstream to the most extreme gene
transcript end position of a coding gene, this column is empty.
For each of the three significance tests (main effects, interaction
test and joint test), we present two tables. The first table shows
all SNPs with a p-value below 1e–4, whereas the second one
(extension “Genic”) shows the SNPs within or close to a coding
gene.
Pathway Analysis
To investigate if genes, belonging to certain metabolic pathways
or biological processes, were enriched in SNPs with low p-values,
gene set enrichment analysis (GSEA) was carried out using the
MAGENTA package. The analysis was performed with the results
from both the main effects test, the interaction test and the
joint test. Upon FDR correction for multiple testing, a total of
seven pathways were significantly enriched in low p-values. An
overview of the significant pathways is provided in Table 2. A
complete overview is provided in the Supplementary Materials
(Supplement 3).
Using GACT software, the fraction of the phenotypic variance
attributable to additive genetic effects was estimated. All
genotyped SNPs passing quality control had a cumulative effect
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FIGURE 1 | Manhattan plot illustrating the main effect of the SNPs on the phenotype, tested via the association between tinnitus and the genotype
without accounting for noise exposure. This highlights the SNPs that lead to an increased risk for tinnitus across both noise-exposed and non-exposed
individuals. None of the SNPs reached the threshold for genome-wide significance (p < 5e−8). The most significant SNPs reach a p-value of 3.4e−7. Two genes
contain SNPs with a p-value below 1e−5 (VDAC1 and NKTR). These SNPs are indicated in green.
accounting for 3.2% of the phenotypic variance in the trait, with
a 95% confidence interval ranging from 0 to 21%.
DISCUSSION AND CONCLUSIONS
To our knowledge, this is the first genome-wide association study
on tinnitus phenotype ever performed, including 916 individuals
aged between 55 and 65, consisting of 167 tinnitus cases and 749
controls. Although none of the SNPs reached the conventional
threshold for genome-wide significance (p < 5.0e–8), and the
proportion of the variance accounted for by all SNPs together is
small, evidence was found for a genetic involvement in tinnitus
through gene set enrichment analysis (GSEA). Throughout the
three methods with which the SNPs were tested for association,
seven pathways with a significant enrichment in significant SNPs
emerged. On the basis of a literature search, we could not find
an obvious link between tinnitus and the RAS pathway, vascular
smooth muscle contraction, NDK Dynamin, and coenzyme A
biosynthesis.
On the other hand, a beneficial effect of antidepressants on
tinnitus has been suggested several times (Baldo et al., 2012;
Beebe Palumbo et al., 2015), and this possibly involves serotonin
(5HT) receptor mediated signaling pathways. Deniz et al.
reported that one allelic variant of the serotonin transporter gene
SLC6A4 was associated with the emotional distress associated
with tinnitus (Deniz et al., 2010). Because the studies are small
and often of limited quality, the results remain inconclusive at
this time (Baldo et al., 2012).Moreover, since anxiety is associated
with both serotonin and tinnitus (Lesch et al., 1996), it is unclear
whether serotonin and tinnitus are directly associated or whether
the apparent link between tinnitus and serotonin is attributable
to anxiety as a confounder. The involvement of genetic variants
in the serotonin mediated signaling pathways would provide a
biological link between the action of antidepressants and the
improvement of tinnitus (Deniz et al., 2010).
The most remarkable associations are those with
endoplasmatic reticulum (ER) stress, and with the NRF2-
mediated oxidative stress response. Oxidative stress plays an
important role in the pathogenesis of noise-induced hearing
loss and noise-induced tinnitus. Delmaghani et al. showed a
direct molecular link between noise-induced hearing loss and
an impaired oxidative stress defense, in a study on mice with
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FIGURE 2 | Manhattan plot illustrating the interaction test between genotype and noise exposure. The p-values test if the effect of the SNP genotype on the
phenotype is altered by noise exposure. This test could highlight SNPs making an individual susceptible to tinnitus, following noise exposure.
an inactivation of the Pejvakin (Pjvk) gene (Delmaghani et al.,
2015). They showed that in regular animals, sensory cells in
the inner hair respond to noise-induced oxidative stress by
upregulating Pjvk expression. This in turns upregulates the
number of peroxysomes, which defend the cell against reactive
oxygen species by restoring the normal redox balance. In mice
with an inactivated Pjvk gene, this defense mechanism against
noise-induced oxidative stress was totally absent. Following
noise exposure, levels of oxidative stress were significantly
increased compared to normal animals, and hearing function
sharply declined. A recent study showed that tinnitus patients
express significantly higher total oxidant status and oxidative
index levels compared to control subjects (Koç et al., 2016)
which can possibly cause dysfunctions in the microcirculation
of the inner ear (Neri et al., 2002, 2006). The exact role of
oxidative stress in tinnitus is still under debate. However,
Honkura et al. showed that NRF2 is an undeniably crucial
player in the defense mechanism against noise-induced oxidative
stress (Honkura et al., 2016). A significant association between
an NRF2 SNP influencing expression and susceptibility for
noise-induced hearing damage was shown in noise-exposed
subjects. In particular a noise notch at 4 kHz was more prevalent
in subjects with a low NRF2 gene expression resulting into
lower antioxidant capacity. In the current study all subjects had
age-related hearing impairment, which is the most common
form of sensorineural hearing loss. Oxidative stress is known to
play a vital role in the development of ARHI. Along the aging
process progressive decline of mitochondrial function emerges
resulting into increased ROS production which in turn elicits
oxidative damage and dysfunction in various tissues (Wallace,
2005). With ARHI being the most frequent cause of tinnitus
development, it can be argued that besides the increase in
susceptibility to hearing loss, a low NRF2 expressor allele also
contributes to tinnitus development.
The endoplasmatic reticulum (ER) overload response, also
referred to as ER stress or the unfolding protein response
(UPR), is an evolutionary conserved response of the ER to the
accumulation of unfolded proteins in the ER lumen. Although
the response is primarily aimed at re-establishing the normal
ER function, prolonged ER stress results in cell death through
apoptosis (Xu et al., 2005). Kalinec et al. showed that the
previously reported ototoxicity of N-acetyl-para-aminophenol
(APAP) acts through oxidative stress and the ER overload
pathway in cells derived from mouse organ of Corti (Kalinec
et al., 2014). ER stress has also been linked to hearing loss in
cellular and animal models for noise induced and age related
Frontiers in Neuroscience | www.frontiersin.org 6 March 2017 | Volume 11 | Article 71
Gilles et al. GWAS on Tinnitus
FIGURE 3 | Manhattan plot illustrating the joint test for genotype and interaction with noise. This test combines the significance of the main effect test
(Figure 1) and the interaction test (Figure 2). Two genes contain SNPs with a p-value below 1e-5 (VDAC1 and NKTR). The SNPs within these genes are shown in
green.
TABLE 2 | Results of Gene set enrichment analysis.
Pathway No. of genes above 75th percentile p-value
Database Expected Observed no. Nominal FDR-corrected
MAIN EFFECTS
RAS Panther 3 9 8.0 e–4 0.02
Vascular Smooth Muscle contraction KEGG 26 43 1.0 e–4 0.03
INTERACTION TEST
Coenzyme A biosynthesis Panther 2 6 1.6 e–3 0.02
5HT2-type receptor mediated signaling pathway 2 6 1.4 e–3 0.03
NDK Dynamin Biocarta 4 11 5.0 e–4 0.05
JOINT TEST
NRF2-mediated oxidative stress response Ingenuity 12 25 4.7 e–5 0.002
ER overload response GOTERM 2 8 1.7 e–5 0.004
hearing loss (Van Rossom et al., 2015; Hu et al., 2016; Xue et al.,
2016). ER stress was suggested to be the earliest molecular event
leading to hearing loss (Hu et al., 2016), and progression could be
delayed with an ER stress inhibitor.
The identification of pathways involved in tinnitus is a useful
first step into a better understanding of the pathophysiology and
the identification of possible drug targets. A further step would
be the identification of individual SNPs associated with tinnitus,
which would deepen our understanding how the symptom arises
on a molecular basis. A potential follow-up study could therefore
focus on genotyping SNPs in genes belonging to the pathways
identified in the current study.
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It is not surprising that the current study has not been
able to find individual SNPs associated with tinnitus. First of
all, this sample set was initially not optimized to study the
genetic causes of tinnitus. It was collected as a cross-sectional
study to investigate age-related hearing impairment, and no
selective enrichment for tinnitus patients was carried out. The
observed prevalence of 18% is in line with previously reported
epidemiological studies (Axelsson and Ringdahl, 1989; Gilles
et al., 2013). There was no matching for other tinnitus risk
factors, although noise exposure was accounted for in the analysis
stage. Hence, the current dataset had limited power to detect
individual SNPs associated with tinnitus. A sensitivity analysis
using the Genetic Power calculator (Purcell et al., 2003) showed
that the current dataset holds 80% power to detect an allele
with a genotype relative risk of 2, under an additive model, at
a genome-wide significance level (p < 5e–8). Since no genome-
wide significant SNPs were found in the current GWAS, it can
be concluded that presumably, no major genes with a genotype
relative risk of 2 or larger in tinnitus exist.
The finding of several pathways significantly enriched in
significant SNPs, seems in contradiction with the lack of SNPs
reaching genome-wide significance and the low heritability.
The genetic signal, picked up using the GSEA, must therefore
reside in the SNPs reaching a nominal, but not a genome-wide,
significance level. For instance, for both the main effect test and
the joint test, there are about 700 SNPs (both genic and non-
genic) reaching a p-value below 1.0e–4. Due to the multitude
of hypotheses tested in a GWAS, it is quite likely that a large
part of these association signals represent false positives, but a
fraction of the SNPs with low p-values will represent a genuine
association signal. This is in line with previous studies into,
amongst others, psychiatric diseases and age-related hearing loss,
where the SNPs with a low p-value not reaching genome-wide
significance, still hold substantial genetic information on the
phenotype (International Schizophrenia Consortium et al., 2009;
Fransen et al., 2015).
A very low heritability estimate was obtained through variance
components analysis as implemented in GACT. This showed
that the cumulative effect of all SNPs in the GWAS on the
phenotype only explains 3.2% of the phenotypic variance in
tinnitus. Several explanations are possible to reconcile this weak
effect of genes with the presence of genetic signals through
the GSEA. A first explanation is the inaccuracy of the current
estimate due to the small sample size. The standard error of
the estimate was 9.2%, which leads to a confidence interval for
the heritability ranging from 0 to 21%. The previously reported
heritability of 11% by Kvestad et al. (2010), falls within this
95% confidence interval. Moreover, the GCTA-GREML method
implemented in GCTA only accounts for the additive genetic
effects of the SNPs in the GWAS. The actual genetic effect
may be larger due to, amongst other, rare SNPs that are not
analyzed in a GWAS or SNP-SNP interactions. The combination
of this very weak effect of all individual SNPs combined, with
the significant results of the GSEA, seems to indicate that only
a very limited number of SNPs are involved in tinnitus, but these
SNPs seem to be confined in a small number of disease-associated
pathways.
Although GWASs have been very successful in the
identification of disease genes, the technique has its limitations.
Most SNP variants genotyped in the current GWAS are
common, typically with a minor allele frequency of at least 5%.
The effects of low-frequency and rare SNPs are not captured.
Novel techniques, such as next-generation sequencing, now
allow to more thoroughly study the role of rare variants in
complex diseases, and traits (Rivas et al., 2011; Gudmundsson
et al., 2012). Moreover, intense research is being carried out
on the role of non-coding variation in the genome. Since most
SNPs identified in GWAS are located outside coding genes, and
probably reside within regulatory regions, subtle alterations in
gene expression level may be a major player in complex traits and
diseases. However, there are very few non-coding SNPs for which
the exact role in gene expression has already been elucidated.
The ideal study design, for a genetic study on tinnitus, would
be a case-control dataset with an equal number of tinnitus cases
and matched controls taking into account potential confounders
such as anxiety, age, hearing loss, occupational/recreational noise
exposure, and distress. Since most genetic effect sizes for complex
traits are small, with the variance explained by a single SNP in the
order of 0.1% of the phenotypic variance and genotype relative
risks around 1.1, detecting such risk alleles is only feasible using
massive sample sizes of 10,000 individuals, collected through
large, international consortia. In addition, these studies should
more carefully study the tinnitus phenotype and take into
account the clinical heterogeneity of the trait. In the current
study, the anamnesis was based upon one simple question in
a questionnaire, without any distinction between the various
subgroups of tinnitus. Tinnitus phenotype has proven to be very
heterogeneous and, as such, the tinnitus phenotype in the present
study was inevitably heterogeneous as well. Further improvement
can be reached by construction of a standardized operation
protocol to collect and phenotype tinnitus patients and controls.
Limiting the tinnitus patients to certain subtypes, excluding for
example somatic tinnitus for which a non-genetic etiology is
likely (Lopez-Escamez et al., 2016), would increase the power of
genetic studies into tinnitus.
So far no large GWAS into tinnitus has been carried out.
The lack of large international studies into tinnitus genetics is
possibly attributable to the general assumption that tinnitus is a
symptom rather than a trait with few genetic factors involved.
Interestingly, a recent longitudinal twin study (Bogo et al., 2016)
estimated the proportion of additive genetic factors in tinnitus
at 40%, which is substantially higher than the 11% previously
estimated by Kvestad (Kvestad et al., 2010).Together with the
results from the current study, the idea seems to emerge that the
role of genetic factors in tinnitus is larger than initially assumed,
and that the identification of SNPs involved in tinnitus is feasible
if sufficiently large sample sets of well-characterized tinnitus and
control subjects are collected.
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